Matches in Wikidata for { <http://www.wikidata.org/entity/Q68203412> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q68203412 description "artikull shkencor i botuar më 01 janar 1991" @default.
- Q68203412 description "artículu científicu espublizáu en xineru de 1991" @default.
- Q68203412 description "im Januar 1991 veröffentlichter wissenschaftlicher Artikel" @default.
- Q68203412 description "scientific article published on 01 January 1991" @default.
- Q68203412 description "wetenschappelijk artikel" @default.
- Q68203412 description "наукова стаття, опублікована в січні 1991" @default.
- Q68203412 name "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 name "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 name "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 type Item @default.
- Q68203412 label "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 label "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 label "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 prefLabel "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 prefLabel "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 prefLabel "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 P1433 Q68203412-49F5DA89-85ED-4335-85AA-300970447D8C @default.
- Q68203412 P1476 Q68203412-C26CF393-B747-4310-8C6B-FB7BE1F544E2 @default.
- Q68203412 P2093 Q68203412-9CA74C40-BF68-4685-A1BA-B7259116B706 @default.
- Q68203412 P2093 Q68203412-CAA87CE3-7393-4072-944C-C48E5E65828D @default.
- Q68203412 P304 Q68203412-BA16004B-BEE5-487A-BD28-62A4CB0AD9E3 @default.
- Q68203412 P31 Q68203412-9958FB79-977D-4A44-8240-531A5EC3F896 @default.
- Q68203412 P356 Q68203412-715316E8-A157-40A0-976E-56A5AD0B9AA3 @default.
- Q68203412 P433 Q68203412-7595648D-5DF9-4F47-B8B8-7DABAE372C2B @default.
- Q68203412 P478 Q68203412-D77431A2-12E4-4AC3-999E-B03CB6FCF469 @default.
- Q68203412 P577 Q68203412-565A8E78-4A88-4695-A65E-2B47EA3733BA @default.
- Q68203412 P698 Q68203412-6A00E7DD-81AC-4668-9C93-542CE012EC22 @default.
- Q68203412 P921 Q68203412-181E7551-0E67-4540-96D8-D450AE278B5A @default.
- Q68203412 P356 000226903 @default.
- Q68203412 P698 1997944 @default.
- Q68203412 P1433 Q2016300 @default.
- Q68203412 P1476 "Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study" @default.
- Q68203412 P2093 "K Kolarić" @default.
- Q68203412 P2093 "Z Mechl" @default.
- Q68203412 P304 "93-96" @default.
- Q68203412 P31 Q13442814 @default.
- Q68203412 P356 "10.1159/000226903" @default.
- Q68203412 P433 "2" @default.
- Q68203412 P478 "48" @default.
- Q68203412 P577 "1991-01-01T00:00:00Z" @default.
- Q68203412 P698 "1997944" @default.
- Q68203412 P921 Q128581 @default.